|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-23.17/-7.15
|
企业价值
275.89M
|
资产负债 |
每股账面净值
10.56
|
现金流量 |
现金流量率
--
|
损益表 |
收益
63.91M
|
每股收益
5.17
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2025/01/11 18:00 EST
同行比较之报价最少15分钟延迟
业务概览
|
|||
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak(R) platform targeting oncologic, viral and autoimmune diseases. |